Back to top

RVMD Maintains Buy Rating -- Price Target Raised to $275 by Guggenheim

RVMD Maintains Buy Rating -- Price Target Raised to $275 by Guggenheim

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Revolution Medicines, Inc. (RVMD)